Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
Massachusetts General Hospital
Wake Forest University Health Sciences
Full-Life Technologies GmbH
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center